GR1003591B - Μεσον για την αυξηση της απελευθερωσης ακετυλχολινης στον εγκεφαλο. - Google Patents

Μεσον για την αυξηση της απελευθερωσης ακετυλχολινης στον εγκεφαλο.

Info

Publication number
GR1003591B
GR1003591B GR20000100145A GR2000100145A GR1003591B GR 1003591 B GR1003591 B GR 1003591B GR 20000100145 A GR20000100145 A GR 20000100145A GR 2000100145 A GR2000100145 A GR 2000100145A GR 1003591 B GR1003591 B GR 1003591B
Authority
GR
Greece
Prior art keywords
anisoyl
acetylcholic
enhances
brain
release
Prior art date
Application number
GR20000100145A
Other languages
English (en)
Other versions
GR20000100145A (el
Inventor
Kazuo Nakamura
Yushiro Tanaka
Masatoshi Shirane
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of GR20000100145A publication Critical patent/GR20000100145A/el
Publication of GR1003591B publication Critical patent/GR1003591B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται στην χρήση Ν-ανισοϋλ-γ-αμινο-βουτυρικού οξέος (Ν-ανισοϋλ-GABA) ή π-ανισικού οξέος για την παρασκευή μίας φαρμακευτικής σύνθεσης που αυξάνει την απελευθέρωση ακετυλχολίνης (ACh) στον εγκέφαλο. Ειδικότερα, η εφεύρεση αναφέρεται στην χρήση Ν-ανισοϋλ-GABA ή π-ανισικού οξέος για την θεραπευτική αγωγή διαταραχών του κιρκάνιου ρυθμού, διαταραχών του ύπνου, διαταραχών με έλλειψη προσοχής και προβληματικών συμπεριφορών. Η εφεύρεση αναφέρεται επίσης σε φαρμακευτικές συνθέσεις που περιέχουν Ν-ανισοϋλ-GABA ή π-ανισικό οξύ ως αποτελεσματικό συστατικό.ΰ
GR20000100145A 1999-04-27 2000-04-24 Μεσον για την αυξηση της απελευθερωσης ακετυλχολινης στον εγκεφαλο. GR1003591B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99108223 1999-04-27

Publications (2)

Publication Number Publication Date
GR20000100145A GR20000100145A (el) 2000-12-29
GR1003591B true GR1003591B (el) 2001-05-22

Family

ID=8238054

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000100145A GR1003591B (el) 1999-04-27 2000-04-24 Μεσον για την αυξηση της απελευθερωσης ακετυλχολινης στον εγκεφαλο.

Country Status (24)

Country Link
US (1) US20030073744A1 (el)
JP (1) JP2000309529A (el)
KR (1) KR100372906B1 (el)
CN (1) CN1277019A (el)
AR (1) AR023763A1 (el)
AT (1) AT408836B (el)
AU (1) AU3011300A (el)
BE (1) BE1013314A3 (el)
BR (1) BR0002381A (el)
CA (1) CA2307022A1 (el)
DE (1) DE10020237A1 (el)
DK (1) DK200000687A (el)
ES (1) ES2176078A1 (el)
FI (1) FI20000977A (el)
FR (1) FR2792833B1 (el)
GB (1) GB2351662A (el)
GR (1) GR1003591B (el)
IE (1) IE20000308A1 (el)
IT (1) IT1318490B1 (el)
NL (1) NL1015043C2 (el)
PT (1) PT102456B (el)
SE (1) SE0001499L (el)
TR (1) TR200001133A2 (el)
ZA (1) ZA200002041B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5273731B2 (ja) * 2009-08-11 2013-08-28 独立行政法人産業技術総合研究所 生体リズムの制御剤
JP7348459B2 (ja) * 2018-11-13 2023-09-21 アニファー テクノロジーズ ピー ティー ワイ エル ティー ディー 動物飼料添加剤の調製におけるアミノ酸のアシル誘導体の使用、飼料用組成物及び動物飼料の調製における飼料用組成物の使用。

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
JPH1081626A (ja) * 1996-09-06 1998-03-31 Kamiyama:Kk チロシナーゼ活性阻害剤
JPH1081607A (ja) * 1996-09-06 1998-03-31 Kamiyama:Kk 抗菌剤

Also Published As

Publication number Publication date
CA2307022A1 (en) 2000-10-27
ZA200002041B (en) 2000-10-27
NL1015043A1 (nl) 2000-10-30
SE0001499L (sv) 2000-10-28
GB2351662A (en) 2001-01-10
CN1277019A (zh) 2000-12-20
NL1015043C2 (nl) 2001-03-30
FI20000977A0 (fi) 2000-04-26
ES2176078A1 (es) 2002-11-16
TR200001133A2 (tr) 2000-11-21
FR2792833A1 (fr) 2000-11-03
ITMI20000914A1 (it) 2001-10-21
IT1318490B1 (it) 2003-08-25
PT102456A (pt) 2000-11-30
KR20010029658A (ko) 2001-04-06
GR20000100145A (el) 2000-12-29
IE20000308A1 (en) 2000-11-29
ATA7162000A (de) 2001-08-15
BR0002381A (pt) 2000-11-07
PT102456B (pt) 2003-04-30
GB0010049D0 (en) 2000-06-14
AU3011300A (en) 2000-11-02
BE1013314A3 (fr) 2001-11-06
JP2000309529A (ja) 2000-11-07
DE10020237A1 (de) 2001-02-08
FI20000977A (fi) 2000-10-27
US20030073744A1 (en) 2003-04-17
AR023763A1 (es) 2002-09-04
AT408836B (de) 2002-03-25
FR2792833B1 (fr) 2002-09-06
ITMI20000914A0 (it) 2000-04-21
DK200000687A (da) 2000-10-28
KR100372906B1 (ko) 2003-02-17
SE0001499D0 (sv) 2000-04-26

Similar Documents

Publication Publication Date Title
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
MXPA04005790A (es) Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
YU25399A (sh) 6-fenilpiridil-2-amino derivati korisni kao nos inhibitori
DE60207383D1 (de) Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen
WO2007100366A3 (en) Quinolone m1 receptor positive allosteric modulators
GEP20043303B (en) Polycycloalkylpurines as Adenosine Receptor Antagonists
BR0317888A (pt) Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
NO20052490D0 (no) Dagsdoseringsenheter for melatonin.
MX9501848A (es) Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
GB0111186D0 (en) Novel compounds
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
NZ513096A (en) Compositions for treating inflammatory response
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
ATE367387T1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
GEP20043267B (en) Adenosine Receptor Antagonists, Methods of Making and Using the Same
MXPA05013226A (es) Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas.
GR3036408T3 (en) Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors
UY26426A1 (es) Nuevos compuestos
WO2002005801A3 (en) Compositions containing diacyltartaric salts of (e)-metanicotine
GR1003591B (el) Μεσον για την αυξηση της απελευθερωσης ακετυλχολινης στον εγκεφαλο.
HUP0301578A3 (en) Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them